Committed to the preservation of vision.
Help bring the first ophthalmic formulation of bevacizumab to people living with wet AMD.

Head of Business Engagement for Strategic Accounts, GPO and Contracting

ABOUT OUTLOOK THERAPEUTICS

Outlook Therapeutics (Nasdaq: OTLK) is a commercial-stage biopharmaceutical company redefining the standard of care in retinal disease. In the United States, our lead product has received FDA approval, making it the first and only FDA-approved ophthalmic formulation of its kind for the treatment of wet AMD, and we are preparing for US commercial launch. Our lead product is also the first ophthalmic formulation of its kind to receive Marketing Authorization from the European Commission and the UK MHRA for the treatment of wet age-related macular degeneration (wet AMD), and has launched across Germany, Austria, and the UK. Driven by the stories of the patients we serve, we are united with the vision-care community around a single goal: a future where everyone with retinal disease can envision a brighter world.

THE OPPORTUNITY

Reports To – Head of Commercial
Location – Remote (US-based); field-based with approximately 30–50% travel
Employment Type – Full-time
Direct Reports – Yes (8)

This is a rare ground-floor moment at a company hitting its commercial inflection point. As a lean, fast-moving organization, we offer scope and ownership that larger companies can’t: your work is visible, your decisions matter, and you’ll help build the function rather than simply maintain it. You’ll partner directly with senior leadership and see a clear line between what you do and patients gaining access to a new treatment option.

You will build and lead Outlook Therapeutics’ national Strategic Account, GPO, and Contracting function from the ground up — operating initially as a player-coach on the company’s most consequential provider relationships while standing up the field organization, playbooks, and governance needed to support a first-in-class ophthalmic biologic launch.

WHAT YOU’LL DO

Strategic Account & GPO Strategy

• Develop and execute the national strategic account and GPO strategy for ophthalmology-focused GPOs, retina MSOs, community-based retina practices, and retina networks.
• Build a segmentation and prioritization framework across patient volume, anti-VEGF utilization, purchasing influence, organizational structure, payer mix, and strategic importance.
• Lead relationship-building and negotiations with executive leadership and contracting decision-makers at priority GPOs and purchasing organizations.
• Track the evolving consolidation of the U.S. retina market — private-equity activity, MSO expansion, acquisitions, and shifts in purchasing influence — and translate it into strategy.
• Build long-term strategic partnerships with priority organizations that extend beyond transactional contracting.

Contracting & Provider Economics

• Structure and negotiate GPO participation, membership, and purchasing agreements, including volume tiers, rebates, administrative fees, and performance requirements.
• Partner with Finance and Market Access to design contract structures that balance provider acquisition economics, utilization, market access objectives, and patient affordability.
• Own contract governance — approval workflows, performance monitoring, compliance requirements, and periodic business reviews.
• Apply deep knowledge of Medicare Part B reimbursement, ASP dynamics, and practice economics to account and contracting decisions, and assess downstream impact to gross-to-net, ASP, and government pricing.
• Partner with Legal, Compliance, Finance, and Government Pricing to ensure every agreement meets applicable laws, regulations, and company policy.

Executive & C-Suite Engagement

• Serve as Outlook Therapeutics’ senior commercial relationship owner for the largest, most strategically important retina provider organizations.
• Build trusted relationships with CEOs, COOs, CFOs, Chief Strategy Officers, practice owners, and physician leadership boards.
• Lead executive-level discussions on contracting, purchasing strategy, and strategic partnership opportunities, and deliver quarterly business reviews to account C-suites.
• Represent Outlook Therapeutics as a credible, long-term partner within the retina community.

Team Building & Leadership

• Design the organizational structure and operating model for a field-based Strategic Account and Business Engagement Manager team.
• Recruit, onboard, coach, and develop Strategic Account Directors and Business Engagement Managers as the function scales.
• Operate in a player-coach capacity initially, personally managing priority accounts while building the broader team.
• Establish account-planning standards, KPIs, and governance, and build a high-performance culture grounded in accountability, compliance, and customer partnership.
  
  Cross-Functional Partnership & Launch Readiness

• Partner with Market Access, Payer Access, Pricing, Government Pricing, Trade & Distribution, Sales, Field Reimbursement, and Medical Affairs to keep account strategy fully integrated with the broader commercial and access strategy.
• Build the strategic account and GPO launch-readiness plan, prioritizing organizations critical to early adoption and establishing pre-launch engagement strategies.
• Define launch KPIs and dashboards to track GPO participation, contracted accounts, covered lives, and contract performance, and flag risks tied to provider consolidation or competitive contracting.
• Own forecasts, budgets, and business cases for strategic account contracting, and present performance, progress, and risks to executive leadership and, when appropriate, the Board.

WHAT YOU’LL BRING

Required

• Bachelor’s degree required; MBA, MPH, PharmD, or other relevant advanced degree preferred.
• 12+ years of progressive experience in biotechnology, pharmaceuticals, specialty biologics, GPOs, strategic accounts, market access, or related healthcare commercial functions, including direct experience in retina and/or ophthalmology.
• 5+ years of senior leadership experience at the Director, Senior Director, Executive Director, or Vice President level.
• Demonstrated experience negotiating complex GPO, strategic account, or large multi-site provider purchasing agreements, including rebates, volume tiers, administrative fees, and performance-based structures.
• Significant experience in a Medicare Part B buy-and-bill environment, preferably involving specialty biologics, with strong understanding of provider acquisition economics, reimbursement, and ASP dynamics.
• Track record engaging and negotiating directly with senior executives — CEOs, COOs, CFOs, practice owners, and physician leadership — and navigating complex, multi-stakeholder organizations.
• Proven ability to operate effectively in a smaller biotechnology or entrepreneurial environment requiring hands-on execution.
• Experience building, leading, and developing high-performing, field-based strategic or key account teams.
• Strong executive communication, negotiation, financial analysis, and presentation skills; ability to travel nationally.

Preferred

• Existing relationships with executive leadership of major retina practices, ophthalmology MSOs, retina networks, GPOs, IDN-affiliated practices, or ASC organizations.
• Experience with anti-VEGF therapies or other physician-administered ophthalmic products, including supporting the launch of a new specialty biologic or physician-administered therapy.
• Experience building a strategic account or GPO capability in a first-launch or emerging biotechnology company.
• Familiarity with the evolving private-equity and consolidation landscape within retina and ophthalmology.
• Working knowledge of government pricing considerations tied to commercial contracting, including ASP, Medicaid Best Price, 340B, and GPO administrative fee structures.

WHAT WE OFFER

• Competitive base salary, annual performance bonus, and equity — so you share in the value you help create
• Comprehensive health coverage: medical, dental, and vision
• 401(k) with company match
• Generous paid time off and company holidays
• A high-trust, low-bureaucracy culture with direct access to leadership and real room to grow
• Mission-driven work that helps preserve sight for patients who are counting on it

COMPENSATION

In keeping with our commitment to pay transparency, the good-faith base salary range for this role is $280,000 – $320,000, with an annual target bonus of 25-30%. This role is also eligible for a meaningful equity grant, reflecting the opportunity to build lasting value at a company at a commercial inflection point. Final compensation reflects experience, skills, and location.

OUR COMMITMENT

Outlook Therapeutics is an equal opportunity employer. We are committed to building an inclusive environment where every team member can do their best work, and we consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law.